Investigating the Abbott-Bioline™ malaria antigen Pf/Pv rapid diagnostic test.

ABSTRACT:

Background

Rapid Diagnostic Tests (RDT) have become an essential tool for the control of malaria worldwide. Their simplicity of use and their reliability make them ideal for the diagnosis of malaria in endemic areas. Numerous brands are now available on the market. In South East Asia, where both Plasmodium falciparum and Plasmodium vivax are prevalent, the Abbott-Bioline™ Malaria Ag Pf/Pv rapid diagnostic test (for the detection of Pf HRP2 and Pv LDH) is deployed widely but, after years of satisfactory performance, its recent sensitivity has been questioned after multiple false negative results were reported.

Methods and results

The study was conducted between October 2024 and January 2025. A field comparison with the First Response^® Malaria Ag pLDH/HRP2 RDT (for

SUBMITTER: Aung MTT 

PROVIDER: S-EPMC12522303 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature